Showing results (191-200 of 210) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic DetectionJimmy A Guo, Hannah I Hoffman, Stuti G Shroff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate CancerDaniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.European Urology|December 11, 2020
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate CancerKosj Yamoah, Shivanshu Awasthi, Brandon A Mahal, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysisLaila A Gharzai, Ralph Jiang, David Wallington, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.Cancer Genetics|September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)Nishwant Swami, William L Hwang, Jimmy A Guo, et al.Prostate Cancer and Prostatic Diseases|April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifierJeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.JCO Precision Oncology|January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the ProstateWilliam A Hall, Nick Fishbane, Yang Liu, et al.European Urology|May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate CancerAmar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.Pageof 21